Delivery Order SPE2DB22D3016-SPE2DB25FADU0
Award Date
11/18/24
Potential Completion Date
11/19/24
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,831.84 and a completion date of December 20, 2024. This award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $9,179.99 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as...
This federal contract award is for the delivery of REXULTI 1 MG Tablets in quantities of 30's, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,192.98 Delivery Order contract has a firm fixed price, with a period of performance through July 1, 2024. The contracting agency is the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the supply of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $36,201.18, was awarded to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, on September 5, 2024. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of September 6, 2024. There is no set-aside designation mentioned for this contract....
This federal contract award is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,420.21, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price type and has a ceiling value of $14,605.44 with a completion date of January 12, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans Affairs (VA). The contract is a Delivery Order with a Firm Fixed Price of $5,810.14 and an ultimate completion date of April 22, 2024....
This federal contract award is a delivery order valued at $2,584.79 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, with a period of performance through December 18, 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $7,056.20 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, on May 21, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a major supplier of pharmaceutical products and...
This federal contract award is for the delivery of REXULTI 0.5 MG TABLET 30S pharmaceutical products to the Defense Logistics Agency (DLA). The $6,034.90 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of May 11, 2023 and was awarded on May 10, 2023. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical...